Form 4 for ORGO Organogenesis Holdings Inc.
Accepted 2024-12-02 00:00:00 ET · period of report 2024-11-27 · accession 0001062993-24-019881 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2024-12-02 | 2024-11-27 | ORGO | GN 2016 Family Trust u/a/d August 12, 2016 | 10% | D - Sale to Iss | $4.06 | -500.0K | 51.09M | -1.0% | -$2.03M |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Class A Common Stock | 2024-11-27 | D | D | 500,000 | $4.06 | 51,085,403 | D | — | — | (F1) The price reported in Column 4 is the 10-day trailing volume weighted average price of the Class A common stock as of market close on November 26, 2024. (F2) Reflects the total number of securities held by the Group. Only the GN 2016 Family Trust u/a/d August 12, 2016 has a pecuniary interest in the shares redeemed by Organogenesis pursuant to a Stock Repurchase Agreement reflected in the first line of Table I of this Form 4. None of the other members of the Group has a pecuniary interest in such shares, except for Glenn H. Nussdorf, who disclaims ownership of the shares held by the GN 2016 Family Trust u/a/d August 12, 2016, except to the extent of his pecuniary interest therein. |